Curist Acid Relief (famotidine 20 mg tablets)

Manufacturer: Little Pharma, Inc.
Effective date: 2026-07-16
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: daily-update
Hydrated at: 2026-07-21 05:10:13

Label at a glance#

ProductCurist Acid Relief

Active ingredientFAMOTIDINE

Label structure13 sections

Storage and handling

Other information read the directions and warning before use store at 20°-25°C (68°-77°F) protect from moisture

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-844-243-1241

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

curistrelief.com

Tips For Managing Heartburn

Do not lie flat or ben dover after eating
Do not wear tight fitting clothing around the abdomen
Do not eat before bedtime
Raise the head of your bed
Avoid heartburn causing foods such as rivh, sp[icy, fatty or fried food, chocolate, caffeine, alcohol, and certain fruits and vegetables
Eat slowly and avoid big meals
If overweight, lose weight
Quit smoking

Important: Read all directions and warnings before use.

Tamper Evident:Do not use if imprinted inner safety seal is torn or missing

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet)

Famotidine USP, 20 mg

OTC - PURPOSE SECTION

Purpose

Acid reducer

SPL UNCLASSIFIED SECTION

(CONTINUED ON BACK OF LABEL)

REV: 032-22-01

NDC 72559-032-22

Distributed by: Little Pharma, Inc.

New York, NY 10023 | Made in India

PEEL HERE

INDICATIONS & USAGE SECTION

Uses

relieves heartburn associated with acid indigestion and sour stomach
prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

WARNINGS SECTION

Warnings

SPL UNCLASSIFIED SECTION

Allergy alert: Do not use if you are allergic to famotidine or other acid reducers

OTC - DO NOT USE SECTION

Do not use

if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
with other acid reducers

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

had heartburn over 3 months. This may be a sign of a more serious condition.
heartburn with lighheadedness, sweating, or dizziness
chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadness
frequent chest pain
frequent wheezing, particularly with heartburn
unexplained weight loss
nausea or vomiting
stomach pain
kidney disease

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking a prescription drug. Acid reducers may interact with certain prescription drugs.

OTC - STOP USE SECTION

Stop use and ask a doctor if

your heartburn continues or worsens
you need to take this product for more than 14 days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years and over:
to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.
to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn
do not use more than 2 tablets in 24 hours
children under 12 years: ask a doctor

STORAGE AND HANDLING SECTION

Other information

read the directions and warning before use
store at 20°-25°C (68°-77°F)
protect from moisture

INACTIVE INGREDIENT SECTION

hydroxypropyl cellulose, hypromellose, macrogol, magnesium stearate, microcrystalline cellulose, pre-gelatinized starch, sodium starch glycolate, talc, titanium dioxide, triacetin

OTC - QUESTIONS SECTION

Questions or comments?

Call 1-844-243-1241 or email hi@curistrelief.com

SPL UNCLASSIFIED SECTION

*Maximum strength famotidine tablet available over the counter (OTC) without a prescription

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

curist

Acid Relief

Maximum Strength OTC*

Famotidine Tablets USP, 20 mg

Acid Reducer

Prevents & Relieves Heartburn

Due to Acid Indigestion

200 Tablets

famotidine 200ct

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae	Product name	7	20260317
1e73f975-1ce7-705e-2bcf-788b1b5e24ba	Product name	5	20251124
cf645750-2e70-f6e1-c05a-a52847def5dd	Product name	9	20250312
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
4fdc761c-585e-054b-8ebe-86130a26e4c1	Product name	2	20221205
fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e	Product name	1	20140508

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Curist Acid Relief
Famotidine 20 mg
HYPROMELLOSE 2910 (6 MPA.S)
TALC
TITANIUM DIOXIDE
SODIUM STARCH GLYCOLATE TYPE A
MAGNESIUM STEARATE
TRIACETIN
POLYETHYLENE GLYCOL 4000
FAMOTIDINE
MICROCRYSTALLINE CELLULOSE
HYDROXYPROPYL CELLULOSE (110000 WAMW)
STARCH, CORN

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
72559-032	72559-032-23, 72559-032-22, 72559-032-63

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
SODIUM STARCH GLYCOLATE TYPE A	H8AV0SQX4D	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
TRIACETIN	XHX3C3X673	IACT
POLYETHYLENE GLYCOL 4000	4R4HFI6D95	IACT
FAMOTIDINE	5QZO15J2Z8	ACTIB
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
HYDROXYPROPYL CELLULOSE (110000 WAMW)	5Y0974F5PW	IACT
STARCH, CORN	O8232NY3SJ	IACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
Version	Effective date	Source	Hydrated
2	2026-03-03	full-release	2026-06-01 01:48:40

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A215822-001	FAMOTIDINE	FAMOTIDINE	10MG	TABLET / ORAL			2022-01-28
A215822-002	FAMOTIDINE	FAMOTIDINE	20MG	TABLET / ORAL			2022-01-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 68 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A215822-001	FAMOTIDINE	10MG	TABLET / ORAL	2022-01-28	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A215822-002	FAMOTIDINE	20MG	TABLET / ORAL	2022-01-28	`bb7c543d1eb4…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Curist Acid Relief	FAMOTIDINE 20 MG	Little Pharma, Inc.	0fdfcc7c-aeed-6bd0-e063-6394a90ae52d	2026-07-16	Warnings	Exact identifier ndc (package): 72559-032-22 ndc (package): 72559-032-63 ndc (package): 72559-032-23 ndc (product): 72559-032 ndc11 (package): 72559003263 ndc11 (package): 72559003223 ndc11 (package): 72559003222 spl id: 56c07eb7-07fe-00c1-e063-6394a90aa202 spl set id: 0fdfcc7c-aeed-6bd0-e063-6394a90ae52d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.